The expression of PD-L1 in melanoma, non-small-cell lung cancer, and gastric cancer was higher than that in adjacent tissues, and survival analysis suggests that PD-L1 might be a predictor of tumor prognosis [24–26]. Here, CD274 is linked to non-small cell lung carcinoma.